A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver Disease
Clinical trial NCT05308160 · UNKNOWN
Trial details
- NCT number
- NCT05308160
- Sponsor
- National Taiwan University Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-28
- Primary completion
- 2023-06-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.